Market Research Logo

Botswana Pharmaceuticals and Healthcare Report Q4 2017

Botswana Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Botswana's pharmaceutical sector is expected to achieve bullish growth rates over our forecast period, more than doubling its small market size. The government will remain committed to improving healthcare infrastructure in the country and to tackling the nation's high communicable disease burden, particularly HIV/AIDS. However, the country's small market size will dampen multinational interest, with drugmakers choosing South Africa as a regional hub.

Headline Expenditure Projections

Pharmaceuticals: BWP2.05bn (USD188mn) in 2016 to BWP2.23bn (USD211mn) in 2017; +9.0% in local currency terms and +12.2% in US dollar terms.

Healthcare: BWP9.00bn (USD827mn) in 2016 to BWP9.78bn (USD925mn) in 2017; +8.6% in local currency terms and +11.9% in US dollar terms.

Risk/Rewards Index Sub-Saharan Africa is a region with high variability of market attractiveness for innovative drugmakers. While certain markets hold significant opportunities for the commercialisation of pharmaceuticals, the region itself lags behind global standards in all areas given its underdeveloped nature. As such, it is vital that companies appreciate the varying levels of investment risks and rewards that are present in the markets in Sub-Saharan Africa. BMI's Innovative Pharmaceuticals Risk/Reward Index tool, which provides a globally comparative and numerically based assessment of a market's attractiveness for companies looking to launch a high-value drug, was established to address this.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Botswana 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Botswana 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Botswana 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Botswana 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Botswana 2013-2021)
Pharmaceutical Trade
Table: Pharmaceutical Trade Data And Forecasts (Botswana 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Botswana 2015-2021)
Industry Risk/Reward Index
Sub-Saharan Africa Pharmaceuticals: Small Market Sizes Weaken Attractiveness To Innovative Drugmakers
Regulatory Review
Intellectual Property Issues
Pricing & Reimbursement Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Gemi Pharmacure
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Botswana 1990-2025)
Table: Key Population Ratios (Botswana 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Botswana 1990-2025)
Table: Population By Age Group (Botswana 1990-2025)
Table: Population By Age Group % (Botswana 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report